Exome sequencing reveals mutant genes with low penetrance involved in MEN2A-associated tumorigenesis

Discovery and saturation analysis of cancer genes across 21 tumour types

(2014) Michael S. Lawrence et al.   NATURE

Mutational heterogeneity in cancer and the search for new cancer-associated genes

(2013) Michael S. Lawrence et al.   NATURE

Vandetanib for the Treatment of Medullary Thyroid Cancer

(2012) N. G. Chau et al.   CLINICAL CANCER RESEARCH

Whole-Exome Sequencing Studies of Nonhereditary (Sporadic) Parathyroid Adenomas

(2012) Paul J. Newey et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Identification of Somatic Mutations in Parathyroid Tumors Using Whole-Exome Sequencing

(2012) M. Kyle Cromer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations inRETandRAS

(2012) Nishant Agrawal et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Chemical genetic discovery of targets and anti-targets for cancer polypharmacology

(2012) Arvin C. Dar et al.   NATURE

Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series

(2012) Raffaele Ciampi et al.   THYROID

High-resolution analysis of alterations in medullary thyroid carcinoma genomes

(2011) Karin Flicker et al.   INTERNATIONAL JOURNAL OF CANCER

Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer

(2011) Razelle Kurzrock et al.   JOURNAL OF CLINICAL ONCOLOGY

Progress in Molecular Targeted Therapy for Thyroid Cancer: Vandetanib in Medullary Thyroid Cancer

(2011) Benjamin Solomon et al.   JOURNAL OF CLINICAL ONCOLOGY

Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma

(2011) A Macià et al.   ONCOGENE

Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study

(2010) Martin Kocher et al.   JOURNAL OF CLINICAL ONCOLOGY

Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma

(2010) Luxia Tu et al.   Molecular Cancer

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

(2010) Shinichi Yachida et al.   NATURE

Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer

(2009) Deborah Silvera et al.   NATURE CELL BIOLOGY

Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association

(2009) Richard T. Kloos (Chair) et al.   THYROID

Synergistic Effect of Oncogenic RET and Loss of p18 on Medullary Thyroid Carcinoma Development

(2008) W. van Veelen et al.   CANCER RESEARCH

eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy

(2008) Francisco Ramírez-Valle et al.   JOURNAL OF CELL BIOLOGY

High Resolution Array-Comparative Genomic Hybridization Profiling Reveals Deoxyribonucleic Acid Copy Number Alterations Associated with Medullary Thyroid Carcinoma

(2008) Lei Ye et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

(2008) S. Jones et al.   SCIENCE

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

(2008) D. W. Parsons et al.   SCIENCE